| 000 | 01667 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513170754.0 | ||
| 264 | 0 | _c19990427 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0950-9240 | ||
| 024 | 7 |
_a10.1038/sj.jhh.1000749 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInada, Y | |
| 245 | 0 | 0 |
_aPharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action. _h[electronic resource] |
| 260 |
_bJournal of human hypertension _cJan 1999 |
||
| 300 |
_aS75-80 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
| 650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aAorta _xdrug effects |
| 650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCircadian Rhythm _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 | _aReceptor, Angiotensin, Type 1 |
| 650 | 0 | 4 | _aReceptor, Angiotensin, Type 2 |
| 650 | 0 | 4 | _aTetrazoles |
| 700 | 1 | _aOjima, M | |
| 700 | 1 | _aKanagawa, R | |
| 700 | 1 | _aMisumi, Y | |
| 700 | 1 | _aNishikawa, K | |
| 700 | 1 | _aNaka, T | |
| 773 | 0 |
_tJournal of human hypertension _gvol. 13 Suppl 1 _gp. S75-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.jhh.1000749 _zAvailable from publisher's website |
| 999 |
_c10036830 _d10036830 |
||